nodes	percent_of_prediction	percent_of_DWPC	metapath
Melphalan—Arterial thrombosis—Niacin—atherosclerosis	0.0221	0.0267	CcSEcCtD
Melphalan—Sensation of warmth—Niacin—atherosclerosis	0.0221	0.0267	CcSEcCtD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—ESAM—atherosclerosis	0.0163	0.112	CbGpPWpGaD
Melphalan—Foetor hepaticus—Ezetimibe—atherosclerosis	0.012	0.0145	CcSEcCtD
Melphalan—Blood creatine phosphokinase increased—Rosuvastatin—atherosclerosis	0.0119	0.0143	CcSEcCtD
Melphalan—Foetor hepaticus—Simvastatin—atherosclerosis	0.0114	0.0138	CcSEcCtD
Melphalan—Transaminases increased—Lovastatin—atherosclerosis	0.0114	0.0137	CcSEcCtD
Melphalan—Transaminases increased—Ezetimibe—atherosclerosis	0.0112	0.0135	CcSEcCtD
Melphalan—Ibuprofen—THBD—atherosclerosis	0.0109	0.418	CrCbGaD
Melphalan—Transaminases increased—Simvastatin—atherosclerosis	0.0106	0.0129	CcSEcCtD
Melphalan—Foetor hepaticus—Pravastatin—atherosclerosis	0.0103	0.0125	CcSEcCtD
Melphalan—Blood creatine phosphokinase increased—Lovastatin—atherosclerosis	0.0101	0.0121	CcSEcCtD
Melphalan—Liver disorder—Ezetimibe—atherosclerosis	0.00997	0.012	CcSEcCtD
Melphalan—Blood creatine phosphokinase increased—Ezetimibe—atherosclerosis	0.00987	0.0119	CcSEcCtD
Melphalan—Transaminases increased—Pravastatin—atherosclerosis	0.00963	0.0116	CcSEcCtD
Melphalan—Interstitial lung disease—Ezetimibe—atherosclerosis	0.0096	0.0116	CcSEcCtD
Melphalan—Liver disorder—Simvastatin—atherosclerosis	0.0095	0.0115	CcSEcCtD
Melphalan—Blood creatine phosphokinase increased—Simvastatin—atherosclerosis	0.00941	0.0114	CcSEcCtD
Melphalan—Rhabdomyolysis—Rosuvastatin—atherosclerosis	0.00924	0.0112	CcSEcCtD
Melphalan—Interstitial lung disease—Simvastatin—atherosclerosis	0.00915	0.011	CcSEcCtD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—AHR—atherosclerosis	0.00864	0.0594	CbGpPWpGaD
Melphalan—Liver disorder—Pravastatin—atherosclerosis	0.00859	0.0104	CcSEcCtD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—OLR1—atherosclerosis	0.00855	0.0588	CbGpPWpGaD
Melphalan—Blood creatine phosphokinase increased—Pravastatin—atherosclerosis	0.00851	0.0103	CcSEcCtD
Melphalan—Interstitial lung disease—Pravastatin—atherosclerosis	0.00827	0.00999	CcSEcCtD
Melphalan—Neoplasm malignant—Ezetimibe—atherosclerosis	0.00796	0.0096	CcSEcCtD
Melphalan—Rhabdomyolysis—Lovastatin—atherosclerosis	0.00783	0.00945	CcSEcCtD
Melphalan—Rhabdomyolysis—Ezetimibe—atherosclerosis	0.00768	0.00927	CcSEcCtD
Melphalan—Skin ulcer—Niacin—atherosclerosis	0.00764	0.00922	CcSEcCtD
Melphalan—Feeling hot—Niacin—atherosclerosis	0.00758	0.00915	CcSEcCtD
Melphalan—Ibuprofen—PLAT—atherosclerosis	0.0075	0.286	CrCbGaD
Melphalan—Tingling sensation—Niacin—atherosclerosis	0.0074	0.00893	CcSEcCtD
Melphalan—Rhabdomyolysis—Simvastatin—atherosclerosis	0.00732	0.00884	CcSEcCtD
Melphalan—Vasculitis—Lovastatin—atherosclerosis	0.0071	0.00857	CcSEcCtD
Melphalan—Vasculitis—Ezetimibe—atherosclerosis	0.00696	0.0084	CcSEcCtD
Melphalan—Hepatocellular injury—Ezetimibe—atherosclerosis	0.00679	0.0082	CcSEcCtD
Melphalan—Rhabdomyolysis—Niacin—atherosclerosis	0.00672	0.00812	CcSEcCtD
Melphalan—Vasculitis—Simvastatin—atherosclerosis	0.00664	0.00801	CcSEcCtD
Melphalan—Rhabdomyolysis—Pravastatin—atherosclerosis	0.00662	0.00799	CcSEcCtD
Melphalan—Hepatocellular injury—Simvastatin—atherosclerosis	0.00648	0.00782	CcSEcCtD
Melphalan—SLC7A5—Basigin interactions—MMP1—atherosclerosis	0.00646	0.0445	CbGpPWpGaD
Melphalan—Renal failure acute—Rosuvastatin—atherosclerosis	0.00643	0.00776	CcSEcCtD
Melphalan—Hyperuricaemia—Niacin—atherosclerosis	0.00641	0.00774	CcSEcCtD
Melphalan—SLC7A5—Basigin interactions—CAV1—atherosclerosis	0.0062	0.0426	CbGpPWpGaD
Melphalan—Blood uric acid increased—Niacin—atherosclerosis	0.00606	0.00731	CcSEcCtD
Melphalan—Vasculitis—Pravastatin—atherosclerosis	0.006	0.00724	CcSEcCtD
Melphalan—Hepatocellular injury—Pravastatin—atherosclerosis	0.00586	0.00707	CcSEcCtD
Melphalan—Skin exfoliation—Niacin—atherosclerosis	0.00568	0.00686	CcSEcCtD
Melphalan—Haemolytic anaemia—Lovastatin—atherosclerosis	0.00557	0.00672	CcSEcCtD
Melphalan—Neuropathy—Pravastatin—atherosclerosis	0.0055	0.00664	CcSEcCtD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—SELP—atherosclerosis	0.00537	0.0369	CbGpPWpGaD
Melphalan—Haemolytic anaemia—Simvastatin—atherosclerosis	0.00521	0.00629	CcSEcCtD
Melphalan—Atrial fibrillation—Simvastatin—atherosclerosis	0.00496	0.00599	CcSEcCtD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—THBD—atherosclerosis	0.00481	0.0331	CbGpPWpGaD
Melphalan—Haemolytic anaemia—Pravastatin—atherosclerosis	0.00471	0.00569	CcSEcCtD
Melphalan—Renal failure acute—Pravastatin—atherosclerosis	0.00461	0.00556	CcSEcCtD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—SELE—atherosclerosis	0.00456	0.0314	CbGpPWpGaD
Melphalan—Atrial fibrillation—Niacin—atherosclerosis	0.00456	0.0055	CcSEcCtD
Melphalan—Liver function test abnormal—Ezetimibe—atherosclerosis	0.00455	0.0055	CcSEcCtD
Melphalan—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.00448	0.00541	CcSEcCtD
Melphalan—Jaundice—Rosuvastatin—atherosclerosis	0.00446	0.00538	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—ESAM—atherosclerosis	0.00441	0.0303	CbGpPWpGaD
Melphalan—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.00432	0.00522	CcSEcCtD
Melphalan—Hepatitis—Rosuvastatin—atherosclerosis	0.0041	0.00495	CcSEcCtD
Melphalan—Liver function test abnormal—Niacin—atherosclerosis	0.00399	0.00481	CcSEcCtD
Melphalan—Liver function test abnormal—Pravastatin—atherosclerosis	0.00393	0.00474	CcSEcCtD
Melphalan—Neuropathy peripheral—Lovastatin—atherosclerosis	0.0038	0.00458	CcSEcCtD
Melphalan—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.00373	0.0045	CcSEcCtD
Melphalan—Jaundice—Ezetimibe—atherosclerosis	0.0037	0.00447	CcSEcCtD
Melphalan—Arrhythmia—Rosuvastatin—atherosclerosis	0.00367	0.00443	CcSEcCtD
Melphalan—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.00359	0.00434	CcSEcCtD
Melphalan—Neuropathy peripheral—Simvastatin—atherosclerosis	0.00355	0.00429	CcSEcCtD
Melphalan—Jaundice—Simvastatin—atherosclerosis	0.00353	0.00426	CcSEcCtD
Melphalan—Hepatitis—Lovastatin—atherosclerosis	0.00348	0.0042	CcSEcCtD
Melphalan—Ibuprofen—CXCL8—atherosclerosis	0.00345	0.132	CrCbGaD
Melphalan—Hepatitis—Ezetimibe—atherosclerosis	0.00341	0.00412	CcSEcCtD
Melphalan—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00335	0.00405	CcSEcCtD
Melphalan—Hepatitis—Simvastatin—atherosclerosis	0.00325	0.00393	CcSEcCtD
Melphalan—Stomatitis—Niacin—atherosclerosis	0.00324	0.00392	CcSEcCtD
Melphalan—Jaundice—Niacin—atherosclerosis	0.00324	0.00392	CcSEcCtD
Melphalan—Flushing—Lovastatin—atherosclerosis	0.00323	0.0039	CcSEcCtD
Melphalan—Neuropathy peripheral—Pravastatin—atherosclerosis	0.00321	0.00388	CcSEcCtD
Melphalan—Jaundice—Pravastatin—atherosclerosis	0.00319	0.00386	CcSEcCtD
Melphalan—Flushing—Ezetimibe—atherosclerosis	0.00317	0.00382	CcSEcCtD
Melphalan—Cough—Rosuvastatin—atherosclerosis	0.00312	0.00376	CcSEcCtD
Melphalan—Immune system disorder—Ezetimibe—atherosclerosis	0.00308	0.00372	CcSEcCtD
Melphalan—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00307	0.00371	CcSEcCtD
Melphalan—Alopecia—Lovastatin—atherosclerosis	0.00307	0.00371	CcSEcCtD
Melphalan—Myalgia—Rosuvastatin—atherosclerosis	0.00304	0.00367	CcSEcCtD
Melphalan—Flushing—Simvastatin—atherosclerosis	0.00302	0.00364	CcSEcCtD
Melphalan—Alopecia—Ezetimibe—atherosclerosis	0.00301	0.00364	CcSEcCtD
Melphalan—Haemoglobin—Niacin—atherosclerosis	0.003	0.00362	CcSEcCtD
Melphalan—Hepatitis—Niacin—atherosclerosis	0.00299	0.00361	CcSEcCtD
Melphalan—Haemorrhage—Niacin—atherosclerosis	0.00299	0.00361	CcSEcCtD
Melphalan—Hepatitis—Pravastatin—atherosclerosis	0.00294	0.00355	CcSEcCtD
Melphalan—Infection—Rosuvastatin—atherosclerosis	0.0029	0.0035	CcSEcCtD
Melphalan—Alopecia—Simvastatin—atherosclerosis	0.00287	0.00347	CcSEcCtD
Melphalan—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00285	0.00345	CcSEcCtD
Melphalan—Flushing—Niacin—atherosclerosis	0.00277	0.00335	CcSEcCtD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IFNG—atherosclerosis	0.00274	0.0189	CbGpPWpGaD
Melphalan—Anaemia—Ezetimibe—atherosclerosis	0.00274	0.00331	CcSEcCtD
Melphalan—Flushing—Pravastatin—atherosclerosis	0.00273	0.0033	CcSEcCtD
Melphalan—Leukopenia—Lovastatin—atherosclerosis	0.00271	0.00327	CcSEcCtD
Melphalan—Arrhythmia—Niacin—atherosclerosis	0.00267	0.00322	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00266	0.00321	CcSEcCtD
Melphalan—Alopecia—Niacin—atherosclerosis	0.00264	0.00319	CcSEcCtD
Melphalan—Arrhythmia—Pravastatin—atherosclerosis	0.00263	0.00317	CcSEcCtD
Melphalan—Paraesthesia—Rosuvastatin—atherosclerosis	0.00262	0.00316	CcSEcCtD
Melphalan—Anaemia—Simvastatin—atherosclerosis	0.00262	0.00316	CcSEcCtD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—APOB—atherosclerosis	0.0026	0.0179	CbGpPWpGaD
Melphalan—Alopecia—Pravastatin—atherosclerosis	0.0026	0.00314	CcSEcCtD
Melphalan—Cough—Ezetimibe—atherosclerosis	0.00259	0.00313	CcSEcCtD
Melphalan—Chest pain—Lovastatin—atherosclerosis	0.00258	0.00311	CcSEcCtD
Melphalan—Myalgia—Lovastatin—atherosclerosis	0.00258	0.00311	CcSEcCtD
Melphalan—Dyspepsia—Rosuvastatin—atherosclerosis	0.00257	0.0031	CcSEcCtD
Melphalan—Leukopenia—Simvastatin—atherosclerosis	0.00254	0.00306	CcSEcCtD
Melphalan—Chest pain—Ezetimibe—atherosclerosis	0.00253	0.00305	CcSEcCtD
Melphalan—Myalgia—Ezetimibe—atherosclerosis	0.00253	0.00305	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00251	0.00303	CcSEcCtD
Melphalan—Pain—Rosuvastatin—atherosclerosis	0.00249	0.00301	CcSEcCtD
Melphalan—Anaphylactic shock—Lovastatin—atherosclerosis	0.00247	0.00298	CcSEcCtD
Melphalan—Infection—Lovastatin—atherosclerosis	0.00245	0.00296	CcSEcCtD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IL1B—atherosclerosis	0.00245	0.0168	CbGpPWpGaD
Melphalan—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00242	0.00293	CcSEcCtD
Melphalan—Thrombocytopenia—Lovastatin—atherosclerosis	0.00242	0.00292	CcSEcCtD
Melphalan—Chest pain—Simvastatin—atherosclerosis	0.00241	0.00291	CcSEcCtD
Melphalan—Myalgia—Simvastatin—atherosclerosis	0.00241	0.00291	CcSEcCtD
Melphalan—Infection—Ezetimibe—atherosclerosis	0.00241	0.00291	CcSEcCtD
Melphalan—Ibuprofen—PPARG—atherosclerosis	0.00239	0.0911	CrCbGaD
Melphalan—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00237	0.00286	CcSEcCtD
Melphalan—Anaemia—Pravastatin—atherosclerosis	0.00237	0.00286	CcSEcCtD
Melphalan—Anorexia—Lovastatin—atherosclerosis	0.00236	0.00284	CcSEcCtD
Melphalan—Skin disorder—Ezetimibe—atherosclerosis	0.00235	0.00284	CcSEcCtD
Melphalan—Leukopenia—Niacin—atherosclerosis	0.00233	0.00281	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—OLR1—atherosclerosis	0.00232	0.0159	CbGpPWpGaD
Melphalan—Urticaria—Rosuvastatin—atherosclerosis	0.00232	0.0028	CcSEcCtD
Melphalan—Anaphylactic shock—Simvastatin—atherosclerosis	0.00231	0.00279	CcSEcCtD
Melphalan—Oedema—Simvastatin—atherosclerosis	0.00231	0.00279	CcSEcCtD
Melphalan—Infection—Simvastatin—atherosclerosis	0.0023	0.00277	CcSEcCtD
Melphalan—Leukopenia—Pravastatin—atherosclerosis	0.00229	0.00277	CcSEcCtD
Melphalan—Cough—Niacin—atherosclerosis	0.00227	0.00274	CcSEcCtD
Melphalan—Thrombocytopenia—Simvastatin—atherosclerosis	0.00226	0.00273	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00225	0.00272	CcSEcCtD
Melphalan—Cough—Pravastatin—atherosclerosis	0.00223	0.0027	CcSEcCtD
Melphalan—Paraesthesia—Lovastatin—atherosclerosis	0.00222	0.00268	CcSEcCtD
Melphalan—Myalgia—Niacin—atherosclerosis	0.00221	0.00267	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00221	0.00267	CcSEcCtD
Melphalan—Anorexia—Simvastatin—atherosclerosis	0.0022	0.00266	CcSEcCtD
Melphalan—Dyspnoea—Lovastatin—atherosclerosis	0.0022	0.00266	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.0022	0.00265	CcSEcCtD
Melphalan—Chest pain—Pravastatin—atherosclerosis	0.00218	0.00263	CcSEcCtD
Melphalan—Myalgia—Pravastatin—atherosclerosis	0.00218	0.00263	CcSEcCtD
Melphalan—Paraesthesia—Ezetimibe—atherosclerosis	0.00218	0.00263	CcSEcCtD
Melphalan—Dyspepsia—Lovastatin—atherosclerosis	0.00218	0.00263	CcSEcCtD
Melphalan—Dyspnoea—Ezetimibe—atherosclerosis	0.00216	0.00261	CcSEcCtD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—MMP1—atherosclerosis	0.00215	0.0148	CbGpPWpGaD
Melphalan—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00215	0.00259	CcSEcCtD
Melphalan—Decreased appetite—Lovastatin—atherosclerosis	0.00215	0.00259	CcSEcCtD
Melphalan—Dyspepsia—Ezetimibe—atherosclerosis	0.00213	0.00258	CcSEcCtD
Melphalan—Fatigue—Lovastatin—atherosclerosis	0.00213	0.00257	CcSEcCtD
Melphalan—Oedema—Niacin—atherosclerosis	0.00212	0.00256	CcSEcCtD
Melphalan—Anaphylactic shock—Niacin—atherosclerosis	0.00212	0.00256	CcSEcCtD
Melphalan—Pain—Lovastatin—atherosclerosis	0.00211	0.00255	CcSEcCtD
Melphalan—Decreased appetite—Ezetimibe—atherosclerosis	0.00211	0.00254	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00211	0.00254	CcSEcCtD
Melphalan—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00209	0.00253	CcSEcCtD
Melphalan—Asthenia—Rosuvastatin—atherosclerosis	0.00209	0.00253	CcSEcCtD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.00209	0.0144	CbGpPWpGaD
Melphalan—Anaphylactic shock—Pravastatin—atherosclerosis	0.00209	0.00252	CcSEcCtD
Melphalan—Oedema—Pravastatin—atherosclerosis	0.00209	0.00252	CcSEcCtD
Melphalan—Fatigue—Ezetimibe—atherosclerosis	0.00209	0.00252	CcSEcCtD
Melphalan—Infection—Pravastatin—atherosclerosis	0.00208	0.00251	CcSEcCtD
Melphalan—Paraesthesia—Simvastatin—atherosclerosis	0.00208	0.00251	CcSEcCtD
Melphalan—Pain—Ezetimibe—atherosclerosis	0.00207	0.0025	CcSEcCtD
Melphalan—Tachycardia—Niacin—atherosclerosis	0.00207	0.0025	CcSEcCtD
Melphalan—Pruritus—Rosuvastatin—atherosclerosis	0.00206	0.00249	CcSEcCtD
Melphalan—Skin disorder—Niacin—atherosclerosis	0.00206	0.00249	CcSEcCtD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—CAV1—atherosclerosis	0.00206	0.0142	CbGpPWpGaD
Melphalan—Dyspnoea—Simvastatin—atherosclerosis	0.00206	0.00249	CcSEcCtD
Melphalan—Thrombocytopenia—Pravastatin—atherosclerosis	0.00205	0.00247	CcSEcCtD
Melphalan—Dyspepsia—Simvastatin—atherosclerosis	0.00203	0.00246	CcSEcCtD
Melphalan—Anorexia—Niacin—atherosclerosis	0.00202	0.00244	CcSEcCtD
Melphalan—Decreased appetite—Simvastatin—atherosclerosis	0.00201	0.00243	CcSEcCtD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.00201	0.0138	CbGpPWpGaD
Melphalan—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.002	0.00241	CcSEcCtD
Melphalan—Diarrhoea—Rosuvastatin—atherosclerosis	0.002	0.00241	CcSEcCtD
Melphalan—Fatigue—Simvastatin—atherosclerosis	0.00199	0.00241	CcSEcCtD
Melphalan—Anorexia—Pravastatin—atherosclerosis	0.00199	0.0024	CcSEcCtD
Melphalan—Hypotension—Niacin—atherosclerosis	0.00198	0.00239	CcSEcCtD
Melphalan—Pain—Simvastatin—atherosclerosis	0.00198	0.00239	CcSEcCtD
Melphalan—Urticaria—Lovastatin—atherosclerosis	0.00196	0.00237	CcSEcCtD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—F2—atherosclerosis	0.00196	0.0135	CbGpPWpGaD
Melphalan—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00193	0.00233	CcSEcCtD
Melphalan—Urticaria—Ezetimibe—atherosclerosis	0.00193	0.00232	CcSEcCtD
Melphalan—Paraesthesia—Niacin—atherosclerosis	0.00191	0.0023	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.0019	0.0023	CcSEcCtD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—TGFB1—atherosclerosis	0.0019	0.0131	CbGpPWpGaD
Melphalan—Dyspnoea—Niacin—atherosclerosis	0.00189	0.00228	CcSEcCtD
Melphalan—Paraesthesia—Pravastatin—atherosclerosis	0.00188	0.00227	CcSEcCtD
Melphalan—Dyspepsia—Niacin—atherosclerosis	0.00187	0.00226	CcSEcCtD
Melphalan—Dyspnoea—Pravastatin—atherosclerosis	0.00186	0.00225	CcSEcCtD
Melphalan—Decreased appetite—Niacin—atherosclerosis	0.00184	0.00223	CcSEcCtD
Melphalan—Dyspepsia—Pravastatin—atherosclerosis	0.00184	0.00222	CcSEcCtD
Melphalan—Rash—Rosuvastatin—atherosclerosis	0.00184	0.00222	CcSEcCtD
Melphalan—Dermatitis—Rosuvastatin—atherosclerosis	0.00184	0.00222	CcSEcCtD
Melphalan—Urticaria—Simvastatin—atherosclerosis	0.00184	0.00222	CcSEcCtD
Melphalan—Gastrointestinal disorder—Niacin—atherosclerosis	0.00183	0.00221	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—SERPINC1—atherosclerosis	0.00183	0.0126	CbGpPWpGaD
Melphalan—Hypersensitivity—Lovastatin—atherosclerosis	0.00182	0.0022	CcSEcCtD
Melphalan—Decreased appetite—Pravastatin—atherosclerosis	0.00182	0.00219	CcSEcCtD
Melphalan—Pain—Niacin—atherosclerosis	0.00181	0.00219	CcSEcCtD
Melphalan—Fatigue—Pravastatin—atherosclerosis	0.0018	0.00217	CcSEcCtD
Melphalan—Pain—Pravastatin—atherosclerosis	0.00179	0.00216	CcSEcCtD
Melphalan—Hypersensitivity—Ezetimibe—atherosclerosis	0.00179	0.00216	CcSEcCtD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—TNF—atherosclerosis	0.00178	0.0122	CbGpPWpGaD
Melphalan—Asthenia—Lovastatin—atherosclerosis	0.00177	0.00214	CcSEcCtD
Melphalan—Pruritus—Lovastatin—atherosclerosis	0.00175	0.00211	CcSEcCtD
Melphalan—Asthenia—Ezetimibe—atherosclerosis	0.00174	0.0021	CcSEcCtD
Melphalan—Nausea—Rosuvastatin—atherosclerosis	0.00173	0.00209	CcSEcCtD
Melphalan—Pruritus—Ezetimibe—atherosclerosis	0.00171	0.00207	CcSEcCtD
Melphalan—Hypersensitivity—Simvastatin—atherosclerosis	0.0017	0.00206	CcSEcCtD
Melphalan—Diarrhoea—Lovastatin—atherosclerosis	0.00169	0.00204	CcSEcCtD
Melphalan—Urticaria—Niacin—atherosclerosis	0.00169	0.00204	CcSEcCtD
Melphalan—Urticaria—Pravastatin—atherosclerosis	0.00166	0.002	CcSEcCtD
Melphalan—Asthenia—Simvastatin—atherosclerosis	0.00166	0.002	CcSEcCtD
Melphalan—Diarrhoea—Ezetimibe—atherosclerosis	0.00166	0.002	CcSEcCtD
Melphalan—Pruritus—Simvastatin—atherosclerosis	0.00164	0.00197	CcSEcCtD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.00159	0.0109	CbGpPWpGaD
Melphalan—Diarrhoea—Simvastatin—atherosclerosis	0.00158	0.00191	CcSEcCtD
Melphalan—Vomiting—Lovastatin—atherosclerosis	0.00157	0.0019	CcSEcCtD
Melphalan—Hypersensitivity—Niacin—atherosclerosis	0.00156	0.00189	CcSEcCtD
Melphalan—Rash—Lovastatin—atherosclerosis	0.00156	0.00188	CcSEcCtD
Melphalan—Dermatitis—Lovastatin—atherosclerosis	0.00156	0.00188	CcSEcCtD
Melphalan—Vomiting—Ezetimibe—atherosclerosis	0.00154	0.00186	CcSEcCtD
Melphalan—Hypersensitivity—Pravastatin—atherosclerosis	0.00154	0.00186	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—F3—atherosclerosis	0.00153	0.0106	CbGpPWpGaD
Melphalan—Rash—Ezetimibe—atherosclerosis	0.00153	0.00184	CcSEcCtD
Melphalan—Dermatitis—Ezetimibe—atherosclerosis	0.00153	0.00184	CcSEcCtD
Melphalan—Asthenia—Niacin—atherosclerosis	0.00152	0.00184	CcSEcCtD
Melphalan—Pruritus—Niacin—atherosclerosis	0.0015	0.00181	CcSEcCtD
Melphalan—Asthenia—Pravastatin—atherosclerosis	0.0015	0.00181	CcSEcCtD
Melphalan—Pruritus—Pravastatin—atherosclerosis	0.00148	0.00178	CcSEcCtD
Melphalan—Vomiting—Simvastatin—atherosclerosis	0.00147	0.00177	CcSEcCtD
Melphalan—Nausea—Lovastatin—atherosclerosis	0.00147	0.00177	CcSEcCtD
Melphalan—Rash—Simvastatin—atherosclerosis	0.00146	0.00176	CcSEcCtD
Melphalan—Dermatitis—Simvastatin—atherosclerosis	0.00146	0.00176	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—SELP—atherosclerosis	0.00145	0.01	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—F5—atherosclerosis	0.00145	0.01	CbGpPWpGaD
Melphalan—Diarrhoea—Niacin—atherosclerosis	0.00145	0.00175	CcSEcCtD
Melphalan—Nausea—Ezetimibe—atherosclerosis	0.00144	0.00174	CcSEcCtD
Melphalan—SLC7A5—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.00144	0.00988	CbGpPWpGaD
Melphalan—Diarrhoea—Pravastatin—atherosclerosis	0.00143	0.00173	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—CLU—atherosclerosis	0.00139	0.00954	CbGpPWpGaD
Melphalan—Nausea—Simvastatin—atherosclerosis	0.00137	0.00166	CcSEcCtD
Melphalan—Vomiting—Niacin—atherosclerosis	0.00135	0.00163	CcSEcCtD
Melphalan—Rash—Niacin—atherosclerosis	0.00134	0.00162	CcSEcCtD
Melphalan—Dermatitis—Niacin—atherosclerosis	0.00134	0.00161	CcSEcCtD
Melphalan—Vomiting—Pravastatin—atherosclerosis	0.00133	0.0016	CcSEcCtD
Melphalan—Rash—Pravastatin—atherosclerosis	0.00132	0.00159	CcSEcCtD
Melphalan—Dermatitis—Pravastatin—atherosclerosis	0.00132	0.00159	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—THBD—atherosclerosis	0.0013	0.00897	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.00129	0.00889	CbGpPWpGaD
Melphalan—Nausea—Niacin—atherosclerosis	0.00126	0.00152	CcSEcCtD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.00124	0.00855	CbGpPWpGaD
Melphalan—Nausea—Pravastatin—atherosclerosis	0.00124	0.0015	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—SELE—atherosclerosis	0.00124	0.00851	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—VWF—atherosclerosis	0.0011	0.00758	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.00107	0.00733	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—F7—atherosclerosis	0.00105	0.00723	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.00102	0.00702	CbGpPWpGaD
Melphalan—Ibuprofen—PTGS2—atherosclerosis	0.00101	0.0385	CrCbGaD
Melphalan—SLC7A5—Hemostasis—PLAT—atherosclerosis	0.000938	0.00645	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—CETP—atherosclerosis	0.000921	0.00633	CbGpPWpGaD
Melphalan—Ibuprofen—ALB—atherosclerosis	0.000898	0.0343	CrCbGaD
Melphalan—SLC7A5—Hemostasis—KNG1—atherosclerosis	0.000823	0.00566	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PLAUR—atherosclerosis	0.000816	0.00561	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—PLAT—atherosclerosis	0.000812	0.00558	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.000808	0.00555	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PLG—atherosclerosis	0.000797	0.00548	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—SOD1—atherosclerosis	0.000764	0.00526	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—ALB—atherosclerosis	0.000753	0.00517	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.000732	0.00503	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—IGF2—atherosclerosis	0.000726	0.00499	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—APOB—atherosclerosis	0.000705	0.00485	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—PLG—atherosclerosis	0.00069	0.00475	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.000658	0.00453	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PRKCG—atherosclerosis	0.000654	0.0045	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—CD36—atherosclerosis	0.000639	0.0044	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—HMOX1—atherosclerosis	0.000637	0.00438	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.000634	0.00436	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—APOB—atherosclerosis	0.00061	0.00419	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PDGFB—atherosclerosis	0.00059	0.00405	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—LDLRAP1—atherosclerosis	0.000587	0.00404	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—MMP1—atherosclerosis	0.000583	0.00401	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—CAV1—atherosclerosis	0.000559	0.00384	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—APOA1—atherosclerosis	0.000558	0.00383	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PLTP—atherosclerosis	0.000552	0.00379	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—F2—atherosclerosis	0.000532	0.00366	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—NOS2—atherosclerosis	0.000526	0.00361	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—PPARA—atherosclerosis	0.000515	0.00354	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PIK3CG—atherosclerosis	0.000509	0.0035	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—APOA1—atherosclerosis	0.000483	0.00332	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—LTA4H—atherosclerosis	0.000478	0.00329	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ABCG8—atherosclerosis	0.000478	0.00329	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—CETP—atherosclerosis	0.000469	0.00323	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—IGF1—atherosclerosis	0.000466	0.0032	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—SERPINE1—atherosclerosis	0.000443	0.00304	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—ALB—atherosclerosis	0.000442	0.00304	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—NOS3—atherosclerosis	0.000423	0.00291	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—PLAT—atherosclerosis	0.000413	0.00284	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—ALB—atherosclerosis	0.000383	0.00264	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ALB—atherosclerosis	0.000382	0.00263	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ABCG1—atherosclerosis	0.000378	0.0026	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—FABP4—atherosclerosis	0.000356	0.00245	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—LCAT—atherosclerosis	0.000356	0.00245	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—PLG—atherosclerosis	0.000352	0.00242	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—APOA4—atherosclerosis	0.000349	0.0024	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CYP7A1—atherosclerosis	0.000343	0.00236	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—HMOX1—atherosclerosis	0.000324	0.00223	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CYP27A1—atherosclerosis	0.000317	0.00218	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—APOB—atherosclerosis	0.000311	0.00214	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—VEGFA—atherosclerosis	0.000304	0.00209	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ALOX15—atherosclerosis	0.0003	0.00207	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PLA2G2A—atherosclerosis	0.0003	0.00207	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—APOA2—atherosclerosis	0.0003	0.00207	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ALOX5AP—atherosclerosis	0.0003	0.00207	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ABCG5—atherosclerosis	0.000297	0.00204	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—MAPK3—atherosclerosis	0.000288	0.00198	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—LPA—atherosclerosis	0.000287	0.00197	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—TGFB1—atherosclerosis	0.000279	0.00192	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—BGN—atherosclerosis	0.000278	0.00191	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—APOA5—atherosclerosis	0.000275	0.00189	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PLA2G1B—atherosclerosis	0.000265	0.00182	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—PPARA—atherosclerosis	0.000262	0.0018	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ALOX5—atherosclerosis	0.000255	0.00176	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—APOA1—atherosclerosis	0.000246	0.00169	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—NAMPT—atherosclerosis	0.000229	0.00158	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—LIPC—atherosclerosis	0.000228	0.00157	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—APOC3—atherosclerosis	0.000226	0.00156	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—LDLR—atherosclerosis	0.000225	0.00155	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CETP—atherosclerosis	0.00022	0.00151	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—SCARB1—atherosclerosis	0.00021	0.00145	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—HMGCR—atherosclerosis	0.000199	0.00137	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ALB—atherosclerosis	0.000195	0.00134	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—AKT1—atherosclerosis	0.000194	0.00134	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ABCA1—atherosclerosis	0.000177	0.00122	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—HMOX1—atherosclerosis	0.000152	0.00104	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—APOB—atherosclerosis	0.000146	0.001	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GSTM1—atherosclerosis	0.000142	0.000974	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—LPL—atherosclerosis	0.000139	0.000956	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GPX1—atherosclerosis	0.000136	0.000932	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CD36—atherosclerosis	0.000132	0.000908	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—MTHFR—atherosclerosis	0.000125	0.00086	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PPARA—atherosclerosis	0.000123	0.000844	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—AGT—atherosclerosis	0.000119	0.000817	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—APOE—atherosclerosis	0.000116	0.000801	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CAV1—atherosclerosis	0.000115	0.000794	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—APOA1—atherosclerosis	0.000115	0.000792	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PIK3CG—atherosclerosis	0.000105	0.000723	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PPARG—atherosclerosis	0.000101	0.000698	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—INS—atherosclerosis	9.95e-05	0.000684	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ALB—atherosclerosis	9.12e-05	0.000627	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—NOS3—atherosclerosis	8.73e-05	0.0006	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PTGS2—atherosclerosis	7.98e-05	0.000549	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—AKT1—atherosclerosis	4.01e-05	0.000276	CbGpPWpGaD
